Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
423
|
Wed, 8/9/06, 10:30 AM - 12:20 PM
|
CC-619
|
|
Binary Data - Contributed - Papers
|
Biopharmaceutical Section, Biometrics Section, ENAR
|
|
Chair(s): Keith Soper, Merck & Co., Inc.
|
|
10:35 AM
|
A Multiplicative Heteroscedasticity Model for Clustered Binary Data —  Mitchell Rosen, Omnicare Clinical Research
|
|
10:50 AM
|
Design and Analysis of Active Control Noninferiority Trials with Binary Data — Yu-Yun Ho, Johnson & Johnson Pharmaceutical R&D; Sudhakar Rao, Johnson & Johnson Pharmaceutical R&D; George Chi, Johnson & Johnson Pharmaceutical R&D
|
|
11:05 AM
|
A Note on Sample Size Re-estimation with Interim Binary Data for Double-blind Clinical Trials — Xiaohui Luo, Merck & Co., Inc.; Peng-Liang Zhao, Kyowa Pharmaceutical, Inc.
|
|
11:20 AM
|
More Powerful Analyses of Stratified NonInferiority Trials with Binary Endpoints — Devan V. Mehrotra, Merck Research Laboratories; William W. B. Wang, Merck Research Laboratories
|
|
11:35 AM
|
Estimation of Multiple Response Rates in Clinical Trials with Missing Observations — Myron Chang, University of Florida
|
|
11:50 AM
|
Choice of Working Correlation Structure for a GEE-Based Analysis of Incomplete Longitudinal Binary Data — Priya Kulkarni, Merck Research Laboratories; Devan V. Mehrotra, Merck Research Laboratories; Xiaoming Li, Novartis Pharmaceuticals Corporation
|
|
12:05 PM
|
Constructing Better Binomial Confidence Intervals by Remembering Three Lessons from Normal Data — Craig Borkowf, Centers for Disease Control and Prevention
|
| |
